Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Kentaro Nakano (Kosigaya, Japan), Kentaro Nakano, Kumiya Sugiyama, Takayoshi Fujimatsu, Naruo Yoshida, Ryosuke Souma, Masamitsu Tatewaki, Kenya Kohyama, Hirokuni Hirata, Yasutsugu Fukushima. Risk factors for disseminated intravascular coagulation (DIC) in patients with lung cancer. Eur Respir J 2016; 48: Suppl. 60, 2135

Member's Comments

No comment yet.

Related content which might interest you: Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC) Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Prognostic affect of the chronic obstructive pulmonary disease on the local-advanced stage non-small cell lung cancer Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 A case series of eight patients treated with alectinib including a case of interstitial lung disease Source: International Congress 2016 – Therapeutic trials in lung cancer Year: 2016 Advanced lung cancer inflammation index (ALI): A new pronostic score in patients with non small cell lung cancer Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Prevalence of COPD and emphysema at the time of diagnosis of primary lung cancer Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Surfactant protein-D level as a predictor of prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer Source: International Congress 2016 – Orphan diseases I Year: 2016 Lung diseases infection and risk of lung cancer Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Possible indication for surgical resection of lung cancer associated with combined pulmonary fibrosis and emphysema (CPFE) Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Lung adenocarcinoma mimicking interstitial lung disease showed good response to navelbine monotherapy Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Chronic obstructive pulmonary disease as a predictor of lung cancer mortality Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Clinical effect of pirfenidone on incidence of lung carcinoma in chronic interstitial pneumonia Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Lung cancer and lung tuberculosis: Our results of treatment in the combined lung disease Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016 The impact of pulmonary rehabilitation on preoperative inflammatory markers in lung cancer patients Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Interstitial lung diseases and lung cancer Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Pemetrexed in advanced non-small cell lung cancer patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Advances in the therapy of lung cancer Year: 2013 The impact of chronic obstructive pulmonary disease on survival of the patients with small-cell lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Lung cancer in patient with chronic obstructive pulmonary disease (comorbidity by smokers-a cumulative effect of exogenic and endogenic factors? Part II) Source: Annual Congress 2013 –COPD treatment Year: 2013 Prevalence and risk factors for postoperative pulmonary complications after lung cancer surgery in patients with early stage of COPD Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Neoplasia in patients with ILD; shortened survival Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013